Alpek lifts 2026 EBITDA guidance to $990 million as leverage falls
Alpek raised its 2026 EBITDA guidance to $990 million and cut leverage to 1.8x, while operating free cash flow fell to just $5 million on working capital needs.
- published on Newsmetry
- original source published
the public page opens no earlier than 15 minutes after we detect the story. approved stories may reach the api sooner. connect the api →
what happened
Alpek (ALPEK/A) raised its full-year 2026 EBITDA guidance to $990 million. Comparable EBITDA climbed 101% year on year to $276 million, according to TradingView, which summarized the company's original document.
A $226 million investment in working capital held operating free cash flow to just $5 million, while leverage improved to 1.8x.
why it matters
For investors the picture is mixed: operating earnings and debt levels improved, but cash generation stayed weak. How quickly free cash flow catches up with EBITDA growth will matter for judging whether the higher guidance is durable.
market impact
Alpek: higher guidance and lower debt support the shares, weak free cash flow limits the upside
tags
instruments
sources
- ALPEK/A: FY26 EBITDA guidance rose to $990 million as leverage fell to 1.8x — TradingView, 21 October 2026 at 23:00 UTC
prepared by the newsmetry newsroom with ai assistance from the sources listed below. not investment advice.
the public page opens no earlier than 15 minutes after we detect the story. approved stories may reach the api sooner.
get stories in real time ↗